Business
Newton acquires Founders Optical Lab
Independent optical lab offers ECPs a curated selection of lens designs manufactured in-house from top brands such as Sequel, Neurolens, and others.
Research
New 5-year Syfovre data indicates extended delay of GA progression
GALE extension study findings show delayed GA lesion growth by an estimated 1.5 years in patients receiving continuous treatment.
Research
Nearly 50% of adults with keratoconus still facing high rate of progression
Study finds, across all age groups, patients with advanced disease were most at risk of keratoconus progression.
Pipeline
PolyActiva and RareSight to advance long-acting therapies for pediatric IRDs
Collaboration leverages PolyActiva’s PREZIA drug delivery platform to develop NCE-enabling pharmacologic drugs for early-onset vision loss.
Pipeline
SpyGlass Pharma reports long-term data on bimatoprost IOL system
Positive 36-month findings from an FIH trial and 3-month results from a phase 1/2 study support delivery of sustained IOP reduction and drop-free outcomes for OAG, OHT.
Business
Eyes On Eyecare accelerates growth with new leadership appointment
Leading eyecare digital media and education platform welcomes Rachel Krug as vice president of Sales.
Pipeline
Lilly gains exclusive global rights to MeiraGTx's ophthalmic genetic therapies
Strategic partnership extends to MeiraGTx’s investigational genetic medicine for LCA4-AIPLI-associated congenital blindness among pediatric patients.
Business
LambdaVision raises $7M to advance space-based artificial retina
Biotech is using space and microgravity to produce its protein-based artificial retina, designed to restore vision in retinal degenerative diseased patients.
Research
Antidepressant use may lower AMD risk
Study outlines potential explanations for link between antidepressant use and reduced risk of AMD onset and progression.
Products
OCULUS Smartfield Perimeter launches into space
Compact and portable visual field analyzer device is aiding in ISS research on spaceflight-associated neuro-ocular syndrome (SANS).
Research
RGC thickness may be early retinal indicator with oral HCQ
Screening with SD-OCT may aid in identifying patients with retinal toxicity before visual field loss.
Business
AOAExcel endorses VisionHQ's in-office patient membership plans
Platform offers optometric practices in-house, customizable membership and subscription plans in lieu of traditional vision insurance for patients.
Products
myze launches daily lid-and-lash Manuka honey-based cleanser
The Foam is formulated with manuka honey, offering antimicrobial and anti-inflammatory effects for long-term ocular health.
Events
National Keratoconus Foundation raises awareness ahead of World KC Day
Recognized annually on Nov. 10, this year’s event features the Cones for a Cause campaign to spread the word and support patients across the country.
Pipeline
Outlook Therapeutics resubmits wet AMD BLA for bevacizumab
Company’s third submission of ONS-5010 (bevacizumab-vikg) reportedly addresses prior issues raised in the FDA’s company response letter.
Research
Advanced AMD linked to imbalanced gut microbiome
Though seemingly unrelated, gut flora may play a surprising role in the pathogenesis of age-related macular degeneration (AMD).
Pipeline
Sydnexis reports phase 3 topline data on SYD-101 eye drop for pediatric myopia
The STAR study met both primary and secondary endpoints for low-dose atropine formulation—just days after the FDA’s NDA rejection.
Research
Viatris and Locus Biosciences to develop antibacterial therapies for ophthalmic infections
Collaboration will utilize Locus’ advanced precision drug development platform to address increasing burden of antimicrobial resistance in eye infections.
Pipeline
Viridian submits BLA for veligrotug to treat TED
Company is requesting Priority Review of veli, an IGF-1R monoclonal antibody intravenously-administered to treat chronic TED.
Research